Johnson P R, Hersey P
Br J Cancer. 1976 Apr;33(4):370-8. doi: 10.1038/bjc.1976.61.
The production of graft-versus-host (GVH) reactions in (PVGc X Wistar) F1 hybrids by the transfer of PVGc spleen cells resulted in significant resistance of these recipients to a subsequent challenge with the PVGc leukaemia. Protection was markedly dependent on dose and timing of allogeneic cell transfer and was abrogated by irradiation of the cells prior to transfer. GVH activity was shown to be a prerequisite for induction of the protective effect but was equally effective when produced by the transfer of Wistar spleen cells in place of PVGc cells. These points, plus the fact that invitro investigations of possible immune mechanisms failed to demonstrate cytotoxic immunity in treated rats, suggested a nonspecific "bystander" effect as the mechanism of protection. The implications of such a mechanism are discussed.
通过转移PVGc脾细胞,在(PVGc×Wistar)F1杂种中产生移植物抗宿主(GVH)反应,使得这些受体对随后的PVGc白血病攻击产生显著抗性。保护作用明显取决于同种异体细胞转移的剂量和时间,并且在转移前对细胞进行照射可消除这种保护作用。GVH活性被证明是诱导保护作用的先决条件,但是当用Wistar脾细胞代替PVGc细胞进行转移产生GVH活性时,其效果同样显著。这些情况,再加上对可能的免疫机制进行的体外研究未能在受试大鼠中证明细胞毒性免疫这一事实,表明一种非特异性“旁观者”效应是保护机制。本文讨论了这种机制的意义。